Table 1 Results of islet transplantation in a syngeneic model.

From: Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response

  

No. of animals

Engraftment

Engraftment rate (%)

Days to engraftment (days)

250 islets

Control

3

2

66.7

7, 5

MMC (+)

4

3

75.0

13, 9, 6

200 islets

Control

6

4

66.7

10, 13, 7, 8

MMC (+)

5

3

60.0

13, 13, 6, 11

175 islets

Control

6

3

50.0

8, 12, 10

MMC (+)

7

3

42.9

7, 9, 6

150 islets

Control

8

1

12.5

21

MMC (+)

4

1

25.0

25

  1. A comparison of engraftment rates between the control and mitomycin C (MMC) groups revealed no significant difference in the number of transplanted islet cells.